ArticleFrontiers in pharmacology2021

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation.

Yanmin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.